z-logo
open-access-imgOpen Access
Thymidylate synthase gene polymorphism predicts disease free survival in stage II–III rectal adenocarcinoma patients receiving adjuvant 5-FU-based chemotherapy
Author(s) -
Xin Su,
Songlin Li,
Hui Zhang,
He Xiao,
Chuan Chen,
Ge Wang
Publication year - 2019
Publication title -
chinese clinical oncology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.733
H-Index - 22
eISSN - 2304-3873
pISSN - 2304-3865
DOI - 10.21037/cco.2019.01.10
Subject(s) - medicine , thymidylate synthase , oncology , gastroenterology , colorectal cancer , proportional hazards model , adenocarcinoma , stage (stratigraphy) , chemotherapy , population , fluorouracil , cancer , biology , paleontology , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here